Literature DB >> 28695379

Expression of prostaglandin E2 receptor subtypes in human pterygium and normal conjunctiva: immunohistochemical study.

Erdem Dinç1, Özer Dursun2, Banu Yılmaz3, Mustafa Vatansever4, A Ayça Sarı5, Özlem Yıldırım5, Ufuk Adıgüzel5.   

Abstract

PURPOSE: In the present study, we aimed to evaluate the expression of EP receptors in primary and recurrent human pterygium tissues.
METHODS: Pterygium samples were collected from 65 patients with primary pterygium and 16 patients with recurrent pterygium. Normal conjunctival tissues were collected from nasal interpalpebral area from 17 patients without systemic and any other ocular pathology. Expression of EP receptors was evaluated by immunohistochemistry. The median value for each receptor staining score (RSS) was determined in normal conjunctival specimens. In this study, RSS of > median value was defined as positive staining or high expression and ≤ median value as negative staining or weak expression in specimens. Chi-square test was used for statistical analysis, and p value of less than 0.05 was considered significant.
RESULTS: Stromal expression of EP1 was significantly higher in primary and recurrent pterygium specimens compared to normal conjunctival tissues (p = 0.007 and p = 0.002, respectively). Epithelial expressions of EP2 and EP3 were significantly lower in primary pterygium specimens compared to normal conjunctival tissues (p = 0.005 and p < 0.0001, respectively), and stromal expressions were insignificant. Stromal expression of EP4 was significantly higher in primary and recurrent pterygium specimens compared to normal conjunctival tissues (p = 0.002 and p = 0.012, respectively).
CONCLUSIONS: Expression of EP receptors has been up- or downregulated in primary and recurrent pterygium tissues, and these receptors may play a role in formation and recurrence of pterygium.

Entities:  

Keywords:  EP receptors; Immunohistochemistry; Normal conjunctiva; Prostaglandin E2; Pterygium

Mesh:

Substances:

Year:  2017        PMID: 28695379     DOI: 10.1007/s10792-017-0651-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  27 in total

1.  Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development.

Authors:  Kathleen L Tober; Traci A Wilgus; Donna F Kusewitt; Jennifer M Thomas-Ahner; Takayuki Maruyama; Tatiana M Oberyszyn
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

Review 2.  The science of pterygia.

Authors:  J C Bradley; W Yang; R H Bradley; T W Reid; I R Schwab
Journal:  Br J Ophthalmol       Date:  2009-06-09       Impact factor: 4.638

3.  The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors.

Authors:  Inok Surh; Joyce E Rundhaug; Amy Pavone; Carol Mikulec; Erika Abel; Melissa Simper; Susan M Fischer
Journal:  Mol Carcinog       Date:  2011-07-07       Impact factor: 4.784

4.  Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues.

Authors:  Ursula Schlötzer-Schrehardt; Matthias Zenkel; Rolf M Nüsing
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

5.  Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis.

Authors:  Mayumi Ueta; Toshiyuki Matsuoka; Shuh Narumiya; Shigeru Kinoshita
Journal:  J Allergy Clin Immunol       Date:  2008-11-08       Impact factor: 10.793

6.  Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues--a comparative immunohistochemical study.

Authors:  Sumana Biswas; Parimal Bhattacherjee; Christopher A Paterson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-11       Impact factor: 4.006

7.  Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.

Authors:  Thomas C Putti; Ming Teh; Yoke S Lee
Journal:  Mod Pathol       Date:  2004-04       Impact factor: 7.842

Review 8.  The prostanoid EP4 receptor and its signaling pathway.

Authors:  Utako Yokoyama; Kousaku Iwatsubo; Masanari Umemura; Takayuki Fujita; Yoshihiro Ishikawa
Journal:  Pharmacol Rev       Date:  2013-06-17       Impact factor: 25.468

9.  Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells.

Authors:  Hiroshi Shiraishi; Hideyuki Yoshida; Kazuko Saeki; Yoshiki Miura; Satoko Watanabe; Takuma Ishizaki; Masayuki Hashimoto; Giichi Takaesu; Takashi Kobayashi; Akihiko Yoshimura
Journal:  Int Immunol       Date:  2008-07-17       Impact factor: 4.823

10.  Overexpression of p53 tumor suppressor gene in pterygia.

Authors:  O Weinstein; G Rosenthal; H Zirkin; T Monos; T Lifshitz; S Argov
Journal:  Eye (Lond)       Date:  2002-09       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.